DATROWAY Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic TNBC Who Are Not Candidates ...

The FDA accepted a supplemental biologics license application and granted priority review for Datroway for adults ...

AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for DATROWAY® (datopotamab deruxtecan-dlnk) has been accepted and granted Priority Review in the US for the treatment ...

Researchers have developed a new biomimetic nanocomposite (mPDA-Cas9) for treating triple-negative breast cancer (TNBC) by combining CRISPR/Cas9 gene ...

AstraZeneca and Daiichi Sankyo have received U.S. FDA Priority Review for DATROWAY for metastatic triple negative breast ...

In this video, Azka Ali, MD, medical oncologist at the Cleveland Clinic Taussig Cancer Institute, highlights interesting ...

The National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines in Oncology to include ...

Despite major advances in genetic testing for breast cancer risk prediction, death rates remain disproportionately high among ...

The landscape of triple-negative breast cancer (TNBC) is shifting rapidly. What was once a landscape dominated by standard cytotoxic chemotherapy is now a complex map of immunotherapy, PARP inhibitors ...

Various institutions across Jammu and adjoining regions observed World Cancer Day today with a strong focus on awareness, ...

On this World Cancer Day, we look at where research and availability stand for cancer vaccines.

Jessica Brady, Danielle Leslie and Nina Lopes were all women who died from cancer far too young, but their legacy lives on in ...